Neuropsychological Signature of Mild Cognitive Impairment

Poster No:

191 

Submission Type:

Abstract Submission 

Authors:

Damien Marie1, Dimitra Kokkinou2, Chantal Junker-Tschopp3, Gilles Allali4, Matthias Kliegel5, Andrea Brioschi Guevara4, Giovanni Frisoni6, Clara James2

Institutions:

1Center for Biomedical Imaging, Cognitive and Affective Neuroimaging section, University of Geneva, Geneva, Switzerland, 2Geneva School of Health Sciences, University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland, 3Geneva School of Social Work, University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland, 4Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 5Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland, 6Geneva University Hospitals and University of Geneva, Geneva, Switzerland

First Author:

Damien Marie  
Center for Biomedical Imaging, Cognitive and Affective Neuroimaging section, University of Geneva
Geneva, Switzerland

Co-Author(s):

Dimitra Kokkinou  
Geneva School of Health Sciences, University of Applied Sciences and Arts Western Switzerland
Geneva, Switzerland
Chantal Junker-Tschopp  
Geneva School of Social Work, University of Applied Sciences and Arts Western Switzerland
Geneva, Switzerland
Gilles Allali  
Lausanne University Hospital and University of Lausanne
Lausanne, Switzerland
Matthias Kliegel  
Faculty of Psychology and Educational Sciences, University of Geneva
Geneva, Switzerland
Andrea Brioschi Guevara  
Lausanne University Hospital and University of Lausanne
Lausanne, Switzerland
Giovanni Frisoni  
Geneva University Hospitals and University of Geneva
Geneva, Switzerland
Clara James  
Geneva School of Health Sciences, University of Applied Sciences and Arts Western Switzerland
Geneva, Switzerland

Introduction:

Mild Cognitive Impairment (MCI) represents a cognitive state between normal aging and dementia [1, 2]. MCI does not impact daily life functioning, but impairments occur in various cognitive domains (memory, executive functions, etc. [3]). In addition, increased grey matter atrophy in particular in the hippocampus (HIP) [4], and functional connectivity alterations [5], are prominent features of MCI. Yet, functional connectivity changes associated with atrophy remain underinvestigated [6]. No studies evaluated the degree of independent association between such brain features and performance in various domains. Finally, no studies evaluated the network of relationships between grey matter atrophy, associated functional connectivity and cognitive performance in MCI and healthy aging.

Methods:

26 MCI patients (71.5 ± 7.5 years old, 69% ♀) and 15 healthy controls (HC) were recruited (70.3 ± 4.6 years old, 87% ♀, no difference between groups). Diagnosis was performed by hospital memory clinics. We evaluated group differences in cognition, including the COGTEL [7], a global measure of cognitive function with a linear mixed model with the standardized performance score, z(performance), as the dependent variable (random effect: subject; fixed effects: Age, Site, Group (2 levels: MCI, HC), Psychometric Test (9 levels corresponding to different tests, see Figure 1), Group * Psychometric Test interaction). 3T Siemens Magnetic Resonance Imaging (MRI) data acquisition included structural imaging (MP2RAGE, 1 mm isotropic voxel size) and resting-state functional MRI (EPI, 2.5 mm isotropic voxel size, repetition time = 1.35s, 440 volumes). Grey matter (GM) volume atrophy was evaluated using whole-brain voxel-based morphometry (CAT12). Functional connectivity associated with atrophy was computed with CONN toolbox, following a seed-based approach using the 3 significant clusters of atrophy extracted from the VBM analysis. We used a partial correlation matrix analysis to evaluate independent relationships between behavior and brain features in the full population, and a network-based analysis independently in MCI and HC).

Results:

We report lower performances in MCI compared to HC [F(1, 36.13) = 28.8, p < 0.0001] at the level of each test (Figure 1). A significant GM atrophy in MCI compared to HC in the left, right HIP and an antero-medial region of the cerebellum (p < 0.05 FWE at cluster-level). Significant differences in functional connectivity based on the left HIP atrophy cluster were also present, with an hypoconnectivity in left and right cortico-subcortical sensorimotor and executive function networks in MCI compared to HC (p < 0.05 FDR at cluster-level). In the full population, the partial correlation matrix analysis shows strong positive independent associations between brain features (rho > 0.65), and weak to strong positive associations between independent brain features and cognitive performance (Figure 2). The network-based analysis shows high sparsity in the MCI network (0.90 vs. 0.41 in HC). While the MCI network includes a few associations (8 non-zero edges out of 78), the healthy control network is well connected, presenting a large number of strong associations between features (46 non-zero edges out of 78).
Supporting Image: Figure1.png
   ·Figure1
Supporting Image: Figure2.png
   ·Figure 2
 

Conclusions:

We reproduce the MCI hippocampus atrophy, a prominent feature of this disorder. We confirm that atrophy relates partly to decreased functional connectivity- Hippocampus altered structure/function is associated with poor performance in various domains, in line with previous independent reports relating hippocampus atrophy, hypoconnectivity, and cognitive deficits to MCI-to-dementia conversion [8]. Yet, disconnection occurs between brain features and cognitive performance in MCI, which may be a manifestation of cognitive reserve decline.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1

Higher Cognitive Functions:

Executive Function, Cognitive Control and Decision Making

Learning and Memory:

Learning and Memory Other

Lifespan Development:

Aging 2

Modeling and Analysis Methods:

Multivariate Approaches

Keywords:

Aging
Degenerative Disease
Other - mild cognitive impairment; MCI; voxel-based morphometry; grey matter; seed-based functional connectivity; network-based analysis

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I do not want to participate in the reproducibility challenge.

Please indicate below if your study was a "resting state" or "task-activation” study.

Resting state
Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Patients

Was this research conducted in the United States?

No

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

No

Please indicate which methods were used in your research:

Functional MRI
Structural MRI
Neuropsychological testing

For human MRI, what field strength scanner do you use?

3.0T

Which processing packages did you use for your study?

SPM

Provide references using APA citation style.

1. Busse, A., et al., Mild cognitive impairment: long-term course of four clinical subtypes. Neurology, 2006. 67(12): p. 2176-85.
2. Kaduszkiewicz, H., et al., Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study. Ann Fam Med, 2014. 12(2): p. 158-65.
3. Petersen, R.C., et al., Mild Cognitive Impairment: Clinical Characterization and Outcome. Archives of Neurology, 1999. 56(3): p. 303-308.
4. Nickl-Jockschat, T., et al., Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis. Brain Struct Funct, 2012. 217(1): p. 115-25.
5. Eyler, L.T., et al., Resting State Abnormalities of the Default Mode Network in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. J Alzheimers Dis, 2019. 70(1): p. 107-120.
6. Xie, C., et al., Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients. Psychological Medicine, 2015. 45(9): p. 1799-1810.
7. Ihle, A., et al., The Cognitive Telephone Screening Instrument (COGTEL): A Brief, Reliable, and Valid Tool for Capturing Interindividual Differences in Cognitive Functioning in Epidemiological and Aging Studies. Dement Geriatr Cogn Dis Extra, 2017. 7(3): p. 339-345.
8. Delli Pizzi, S., M. Punzi, and S.L. Sensi, Functional signature of conversion of patients with mild cognitive impairment. Neurobiol Aging, 2019. 74: p. 21-37.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No